Literature DB >> 182723

Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states.

J D Baxter, M Schambelan, D T Matulich, B J Spindler, A A Taylor, F C Bartter.   

Abstract

Aldosterone receptors from rat kidney slices were utilized in a competitive binding technique to analyze the contribution of various steroids to plasma "mineralocorticoid" activity and to assess their possible role in hypertension. To consider simultaneously the plasma binding, steroids were incubated with slices in undiluted plasma; competitor activities for [3H]aldosterone binding were aldosterone, 100%; deoxycorticosterone, 16.2%; cortisol, 0.4%; and 18-hydroxy-deoxy-corticosterone and d18-hydroxy-corticosterone, 0.1%. These steroids were more active in buffer than plasma, suggesting that they bind to plasma and that this reduces their receptor binding. Analysis of the competition data suggests that at normal plasma concentrations, aldosterone occupies the receptors to a major extent, cortisol occupies some of the receptors, and deoxycorticosterone and 8-hydroxydeoxycorticosterone contribute little to receptor occupancy. Two steroids implicated in low-renin essential hypertension, 16beta-hydroxy-dehydro-epiandrosterone and 16-oxoandrostenediol, did not have significant competitor activity. Competitor activity in plasmas from normal subjects taken at 12 noon (upright) was greater than that in those taken at 8 a.m. (supine). Since the 12 noon samples had higher aldosterone and lower cortisol levels than the 8 a.m. samples, the competitor activity under these physiological circumstances reflects aldosterone more than cortisol. The competitor activities of plasmas from patients relative to normal subjects (100+/-12.1%; mean+/-SEM) were: normal renin "essential" hypertension, 117+/-14%; low-renin essential hypertension, 101+/-6.6%; and primary aldosteronism, 176+/-14.3%. Thus a significant increase in activity of steroids that interact with mineralocorticoid receptors was detected in primary aldosteronism (P LESS THAN 0.01) BUT WAS NOT DETECTED IN LOW-RENIN OR NORMAL-RENIN ESSENTIAL HYPERTENSION.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 182723      PMCID: PMC333216          DOI: 10.1172/JCI108504

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Adrenal steroidogenesis in "low renin" or hyporeninemic hypertension.

Authors:  J C Melby; S L Dale
Journal:  J Steroid Biochem       Date:  1975-05       Impact factor: 4.292

2.  The adrenogenital syndrome.

Authors:  A M BONGIOVANNI; A W ROOT
Journal:  N Engl J Med       Date:  1963-06-06       Impact factor: 91.245

3.  The different effects of aldosterone-like steroids and hydrocortisone-like steroids on urinary excretion of potassium and acid.

Authors:  F C BARTTER; P FOURMAN
Journal:  Metabolism       Date:  1962-01       Impact factor: 8.694

4.  Ultrafiltration studies of steroid-protein binding.

Authors:  P S CHEN; I H MILLS; F C BARTTER
Journal:  J Endocrinol       Date:  1961-10       Impact factor: 4.286

5.  Effects of anti-inflammatory steroids on electrolvte metabolism.

Authors:  G W LIDDLE
Journal:  Ann N Y Acad Sci       Date:  1959-10-14       Impact factor: 5.691

6.  A radioreceptor assay for evaluation of the plasma glucocorticoid activity of natural and synthetic steroids in man.

Authors:  P L Ballard; J P Carter; B S Graham; J D Baxter
Journal:  J Clin Endocrinol Metab       Date:  1975-08       Impact factor: 5.958

7.  Sodium and the renin-angiotensin system in essential hypertension and mineralocorticoid excess.

Authors:  M Lebel; M A Schalekamp; D G Beevers; J J Brown; D L Davies; R Fraser; D Kremer; A F Lever; J J Morton; J I Robertson; M Tree; A Wilson
Journal:  Lancet       Date:  1974-08-10       Impact factor: 79.321

8.  Apparently isolated excess deoxycorticosterone in hypertension. A variant of the mineralocorticoid-excess syndrome.

Authors:  J J Brown; R Fraser; D R Love; J B Ferriss; A F Lever; J I Robertson; A Wilson
Journal:  Lancet       Date:  1972-08-05       Impact factor: 79.321

9.  Renal-vein renin in various forms of renal hypertension.

Authors:  J R Stockigt; R D Collins; C A Noakes; M Schambelan; E G Biglieri
Journal:  Lancet       Date:  1972-06-03       Impact factor: 79.321

10.  Estimation of aldosterone, 11-deoxycorticosterone, 18-hydroxy-11-deoxy-corticosterone, corticosterone, cortisol and 11-deoxycortisol in human plasma by gas-liquid chromatography with electron capture detection.

Authors:  P A Mason; R Fraser
Journal:  J Endocrinol       Date:  1975-02       Impact factor: 4.286

View more
  6 in total

1.  Long term observations in a patient with pseudohypoaldosteronism.

Authors:  R J Hogg; J F Marks; D Marver; J C Frolich
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

2.  Receptor recognition of maleyl-albumin induces chemotaxis in human monocytes.

Authors:  M E Haberland; R R Rasmussen; A M Fogelman
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

Review 3.  Low-renin hypertension of childhood.

Authors:  J DiMartino-Nardi; M I New
Journal:  Pediatr Nephrol       Date:  1987-01       Impact factor: 3.714

4.  Receptor dysfunctions in human disease.

Authors:  L H Block; W Tenschert; R Locher; W Siegenthaler; W Vetter
Journal:  Klin Wochenschr       Date:  1981-04-15

5.  The pathogenesis of pseudohyperaldosteronism from carbenoxolone.

Authors:  D Armanini; M Scali; M C Zennaro; I Karbowiak; C Wallace; S Lewicka; P Vecsei; F Mantero
Journal:  J Endocrinol Invest       Date:  1989-05       Impact factor: 4.256

6.  Aldosterone and in vivo mineralocorticoid activity in normotensive and hypertensive man.

Authors:  F Skrabal
Journal:  J R Soc Med       Date:  1979-04       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.